The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer.
Clinical and translational medicine(2023)
摘要
Gut microbiome affects response of treatments in HER2-negative advanced gastric cancer in a treatment-specific way, immunotherapy plus chemotherapy did not equal to a simple superposition of immunotherapy and chemotherapy. Lactobacillus is expected to become a novel choice as an adjuvant agent in promoting the efficacy of immunotherapy in gastric cancer.
更多查看译文
关键词
gut microbiome,gastric cancer,advanced gastric cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要